Global Infertility Treatment Market

Infertility Treatment Market Size, Share, Growth Analysis, By Product(Equipment, Microscopes (Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps), By Procedure(Assisted Reproductive Technology (In Vitro Fertilization [Intracytoplasmic Morphologically Selected Sperm Injection, Gamete Donation], Intracytoplasmic Sperm Injection, Surrogacy)), By Patient Type(Female Infertility Treatment, Male Infertility Treatment), By End User(Fertility Clinics, Hospitals, Surgical Centers, Cryobanks), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2204 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 95 | Figures: 76

Infertility Treatment Market Competitive Landscape

The competitive surroundings of the Infertility Treatment marketplace is dynamic and is characterised by the presence of several key players striving to gain a competitive side via strategic projects and technological improvements. Leading organizations within the enterprise, including fertility clinics, pharmaceutical corporations, and biotechnology businesses, are actively engaged in studies and improvement activities to introduce revolutionary treatments and improve current methodologies.

Top Player’s Company Profiles

  • Merck KGaA
  • Bayer AG
  • Ferring B.V.
  • Astellas Pharma Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Organon International B.V.
  • ReproMed LLC
  • Cooper Surgical, Inc.
  • Vitrolife AB
  • IOLIT Technologies Corporation
  • The Cooper Companies, Inc.
  • Cook Medical LLC
  • FujiFilm Medical Co., Ltd.
  • Sydney IVF Pty Ltd
  • Genea Ltd
  • Nurture Fertility Group
  • Ovation Fertility
  • Shady Grove Fertility
  • CCRM Fertility
  • Pacific Fertility Institute

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

​​Global Infertility Treatment Market size was valued at USD 3.2 Billion in 2022 and is poised to grow from USD 3.40 Billion in 2023 to USD 5.45 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The competitive surroundings of the Infertility Treatment marketplace is dynamic and is characterised by the presence of several key players striving to gain a competitive side via strategic projects and technological improvements. Leading organizations within the enterprise, including fertility clinics, pharmaceutical corporations, and biotechnology businesses, are actively engaged in studies and improvement activities to introduce revolutionary treatments and improve current methodologies. 'Merck KGaA', 'Bayer AG', 'Ferring B.V.', 'Astellas Pharma Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Organon International B.V.', 'ReproMed LLC', 'Cooper Surgical, Inc.', 'Vitrolife AB', 'IOLIT Technologies Corporation', 'The Cooper Companies, Inc.', 'Cook Medical LLC', 'FujiFilm Medical Co., Ltd.', 'Sydney IVF Pty Ltd', 'Genea Ltd', 'Nurture Fertility Group', 'Ovation Fertility', 'Shady Grove Fertility', 'CCRM Fertility', 'Pacific Fertility Institute'

The growth in infertility prices globally, owing to elements such as life-style modifications, delayed parenthood, and environmental influences. This surge inside the wide variety of people and couples going through fertility demanding situations creates a heightened demand for infertility remedy alternatives. Secondly, improvements in scientific technology, specifically in assisted reproductive technology like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have considerably advanced fulfillment fees, making these remedies extra powerful and handy.

Rising Consumer Awareness and Increased Use of Clean Label Products: Rising Consumer Awareness and elevated use of easy label merchandise: The increasing usage of precision medicine methods, mainly in in vitro fertilization (IVF). Genetic testing and screening technology have become more integral, bearing in mind an extra targeted and personalised selection of embryos with better probabilities of a successful implantation, decreasing the hazard of genetic issues. Another vast trend entails the growing acceptance and integration of third-birthday celebration reproduction methods. Surrogacy and egg or sperm donation are gaining broader societal popularity, supplying alternative pathways to parenthood for people and couples facing infertility demanding situations.

North America has a well-set up lifestyle of awareness and acceptance of infertility remedies. There is a greater know-how of the to be had options, mainly to a better charge of adoption of advanced reproductive technologies. The location boasts superior healthcare infrastructure, together with latest fertility clinics and research centers. This infrastructure supports the delivery of modern infertility treatments, contributing to the dominance of North America inside the global marketplace.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

In Vitro Fertilization Market
Buy Now GET FREE SAMPLE
Fertility Supplements Market
Buy Now GET FREE SAMPLE
Assisted Reproductive Technology Market
Buy Now GET FREE SAMPLE
Fertility Testing Devices Market
Buy Now GET FREE SAMPLE
Fertility Test Market
Buy Now GET FREE SAMPLE
Sperm Bank Market
Buy Now GET FREE SAMPLE
Seed Treatment Market
Buy Now GET FREE SAMPLE
Biological Seed Treatment Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Infertility Treatment Market

Report ID: SQMIG35D2204

$5,300
BUY NOW GET FREE SAMPLE